News

BAC Webinar 29th March 2022 - booking is live

Harnessing the epigenetic footprint of cervical samples for breast and ovarian cancer detection and prediction



Speaker

Chiara Herzog, PhD is a postdoctoral researcher at the European Translational Oncology Prevention and Screening (EUTOPS) Institute at the University of Innsbruck, Austria, and honorary research fellow at University College London, UK. She is researching ageing and disease prevention with a focus on epigenetics and is currently co-leading a clinical trial to investigate individual longitudinal health changes following smoking cessation or intermittent fasting.

Her background is in Molecular Medicine and she obtained a PhD in Neuroscience from the University of Edinburgh in 2019. After a year at precision diagnostics company BioClavis, she joined Prof Martin Widschwendter’s team to work in the space of women’s cancer prevention and early detection as well as ageing research.

Webinar title

Harnessing the epigenetic footprint of cervical samples for breast and ovarian cancer detection and prediction

Overview

Our latest research, published in Nature Communications, describes the potential of routine cervical samples for detection and risk prediction of breast and ovarian cancers via assessment of new epigenetic women’s cancer risk identification (WID) signatures. In independent validation sets, breast and ovarian cancers were identified in independent validation sets with AUCs of 0.81 and 0.76, respectively.

In my talk, I will give an introduction and background into our research programme aiming to detect four women’s cancers – breast, ovarian, endometrial, and cervical – using a single test, present current results and introduce the methodology of this new test, and provide an insight into ongoing and future trials looking at longitudinal risk monitoring using the WID test. 



Register for the free webinar on 29th March

Downloads